Mumbai has cemented its crown as India's billionaire capital, leading the M3M Hurun India Rich List 2025 with 451 entrants
Sun Pharma's shares fell 4.86% to an intraday low of Rs 1,636.30 on BSE.
Dilip Shanghvi's focus on research and high-margin drugs future-proofs Sun Pharma.
In 2023, India boasts a formidable lineup of billionaires who have made significant strides in accumulating immense wealth. Topping the list is Mukesh Ambani, the chairman of Reliance Industries, with a staggering net worth of $94.3 billion. His empire spans diverse sectors, including telecommunications, petrochemicals, and retail. Closely following is Gautam Adani, the visionary behind the Adani Group, holding the second position with a formidable net worth of $85.1 billion. His conglomerate is involved in various industries such as infrastructure, energy, logistics, and resources, reflecting his multifaceted success. Securing the third spot is Shapoor Mistry, the force behind the Shapoorji Pallonji Group, with a net worth of $34.1 billion. His influence extends across diverse sectors, including construction, real estate, and infrastructure development. The technology sector is represented by Shiv Nadar, the founder of HCL Tech, who claims the fourth position with a net worth of $32.6 billion. His contributions to the IT industry have been instrumental in shaping India's global technological footprint. Savitri Jindal of the JSW Group secures the fifth position with a net worth of $25.3 billion, showcasing her prominence in the steel and power industries. Following closely is Azim Premji, the founder of Wipro, whose net worth stands at $24.5 billion, highlighting his enduring influence in the IT sector. The pharmaceutical sector is represented by Dilip Shanghvi of Sun Pharma, who claims the seventh spot with a net worth of $20.3 billion. The global steel magnate, Lakshmi Mittal, founder of ArcelorMittal, follows closely with a net worth of $19.8 billion, securing the eighth position. Radhakishan Damani of DMart fame, with a net worth of $19.4 billion, captures the ninth position, reflecting his success in the retail industry. Closing the top ten is Kumar Mangalam Birla of the Aditya Birla Group, with a net worth of $17.7 billion, showcasing his diverse interests in sectors such as metals, cement, and telecommunications. These individuals, as per the Bloomberg Billionaires Index as of December 15, 2023, epitomize the resilience and entrepreneurial spirit that define India's economic landscape, contributing significantly to the nation's growth and global standing.
Suzlon Energy share price: Suzlon, in an exchange filing, said, "Dilip Shanghvi and associates (referred as Investor Group), who had entered into an amended and restated shareholders' agreement with the promoters/promoter group and the company, have informed that the Investor Group has decided to terminate the agreement."
In the past five years, Sun Pharma has undergone a significant transformation. Despite the challenges, including the Ranbaxy acquisition in 2014 which initially impacted profits, founder Dilip Shanghvi implemented a renewed strategy focused on boosting the specialty drugs business and expanding the portfolio through mergers and acquisitions. This resulted in an impressive turnaround, with the company achieving its highest-ever consolidated revenue of Rs 43,279 crore in FY2023.
Founded in 1983, India's largest pharma company Sun Pharma saw some of its toughest times between 2014 and 2018. However, under Dilip Shanghvi, Sun Pharma saw a turnaround. Watch this Visual Story to see how Shanghvi led Sun Pharma to Sun Pharma its highest-ever consolidated revenue of Rs 43,279 crore and net profit of Rs 8,474 crore in FY23.
Sun Pharma Founder & MD Dilip Shanghvi on new targets and the way forward for India’s largest pharma company
Cut to 2023. In FY23, Sun Pharma registered its highest-ever consolidated revenue of Rs 43,279 crore and net profit of Rs 8,474 crore, signalling to the market that the company was back in the game.
With a wealth of $27 billion, Cyrus Poonawalla of Serum Institute of India is the richest healthcare billionaire in the world followed by Dilip Shanghvi & family of Sun Pharmaceutical Industries, who have a net worth of around $17 billion.
Ebitda for the quarter came in at Rs 2,956.50 crore, up 12.4% YoY. Ebitda margin fell 30 basis points YoY to 27% from 27.3% in the year-ago quarter.




